OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...
Platelet transfusion thresholds in according bleeding risk and the presence of bleeding. WHO = World Health Organization. “In practice, we see all too often [that] prophylactic transfusion of ...
Background: Transfusion-dependent bone marrow transplant recipients are routinely transfused with ABO group and RhD-compatible blood components. However, because of the scarcity of RhD-negative blood ...
Australia: Cryopreserved platelets, which can be stored for up to two years, did not demonstrate noninferior effectiveness ...
A preliminary study published in this week's issue of THE LANCET suggests a possible explanation for the biological process responsible for inducing fever and related symptoms after the transfusion of ...
A new international study published in eClinicalMedicine has mapped global blood transfusion practices for life-threatening ...
Four people in three states developed sepsis after receiving bacteria-contaminated platelet transfusions between May and October last year, according to a US government report released Thursday. One ...
To provide evidence-based guidance on the use of platelet transfusion in people with cancer. This guideline updates and replaces the previous ASCO platelet transfusion guideline published initially in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results